Pub Date : 2026-01-01Epub Date: 2025-07-23DOI: 10.1177/11206721251362054
Sophie Vanhaesebrouck, Aleksandra Zecic, Linde Goossens, Annelies Keymeulen, Lara Garabedian, Julie De Meulemeester, Pauline Naessens, Kris De Coen, Koenraad Smets
PurposeRetinopathy of prematurity (ROP) is a blinding disease, however largely preventable by timely detection of severe ROP and treatment when required. Clinical use of the DIGIROP decision support tool (DIGIROP-screen and DIGIROP-birth) can help detecting neonates at high risk of sight-threatening severe ROP needing treatment and to reduce unnecessary screening exams in low-risk infants. External validation is necessary before the tool can be used in clinical decision-making.MethodsRetrospective cohort analysis of all preterm infants who were screened for ROP at the University Hospitals Ghent Belgium from January 1, 2020, to December 31, 2022. Validation of the DIGIROP decision support tools was the primary outcome variable. In a secondary analysis pre-, peri-, and postnatal characteristics were compared in different cohorts.Results311 infants were eligible for routine ROP-screening. Infants with a (gestational age) GA beyond 30 weeks (N = 80) and those who died (N = 19) were excluded resulting in 212 infants eligible entered in DIGIROP-birth. 112 infants did not need to be screened according to DIGIROP-birth. This resulted in 94 infants entered in DIGIROP-screen. These infants had a median GA of 27 weeks, a median birth weight (BW) of 892.5 g, and 62.5% were boys. DIGIROP birth showed a sensitivity of 100%. Most important risk factors for ROP across all subgroups are GA, BW.ConclusionsThe DIGIROP decision support tool demonstrated very high performance in our setting. However, multicenter prospective validation studies with large cohorts should confirm our findings before the use of the model can be generalized in Western NICU's with similar levels of care.
{"title":"Validation of the DIGIROP algorithm in identifying preterm infants at risk for developing retinopathy of prematurity in a Belgian NICU.","authors":"Sophie Vanhaesebrouck, Aleksandra Zecic, Linde Goossens, Annelies Keymeulen, Lara Garabedian, Julie De Meulemeester, Pauline Naessens, Kris De Coen, Koenraad Smets","doi":"10.1177/11206721251362054","DOIUrl":"10.1177/11206721251362054","url":null,"abstract":"<p><p>PurposeRetinopathy of prematurity (ROP) is a blinding disease, however largely preventable by timely detection of severe ROP and treatment when required. Clinical use of the DIGIROP decision support tool (DIGIROP-screen and DIGIROP-birth) can help detecting neonates at high risk of sight-threatening severe ROP needing treatment and to reduce unnecessary screening exams in low-risk infants. External validation is necessary before the tool can be used in clinical decision-making.MethodsRetrospective cohort analysis of all preterm infants who were screened for ROP at the University Hospitals Ghent Belgium from January 1, 2020, to December 31, 2022. Validation of the DIGIROP decision support tools was the primary outcome variable. In a secondary analysis pre-, peri-, and postnatal characteristics were compared in different cohorts.Results311 infants were eligible for routine ROP-screening. Infants with a (gestational age) GA beyond 30 weeks (N = 80) and those who died (N = 19) were excluded resulting in 212 infants eligible entered in DIGIROP-birth. 112 infants did not need to be screened according to DIGIROP-birth. This resulted in 94 infants entered in DIGIROP-screen. These infants had a median GA of 27 weeks, a median birth weight (BW) of 892.5 g, and 62.5% were boys. DIGIROP birth showed a sensitivity of 100%. Most important risk factors for ROP across all subgroups are GA, BW.ConclusionsThe DIGIROP decision support tool demonstrated very high performance in our setting. However, multicenter prospective validation studies with large cohorts should confirm our findings before the use of the model can be generalized in Western NICU's with similar levels of care.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"89-96"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144697920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-08-11DOI: 10.1177/11206721251364409
Caglar Bektas, Betul Seher Uysal, Hasan Diker, Mehmet Cuneyt Ozmen, Kamil Bilgihan
PurposeTo compare the corneal biomechanical characteristics following accelerated cross-linking (A-CXL) and diluted alcohol and iontophoresis-assisted corneal cross-linking (DAI-CXL).MethodsForty-nine eyes from 41 patients who underwent DAI-CXL or A-CXL for progressive keratoconus were included. Visual acuity, topographic, and biomechanical data were analyzed preoperatively and 12 months postoperatively.ResultsA significant decrease in flat keratometry (K1) and thinnest corneal thickness (TCT) was observed in the A-CXL group between baseline and postoperatively (K1, p = 0.001; TCT: p = 0.007). Both groups showed a significant decrease in steep keratometry (K2) and maximum keratometry (Kmax) compared to baseline (K2: p = 0.03, p < 0.001, respectively; Kmax: p < 0.001 for both groups). Postoperatively, highest concavity time (HCT) was significantly lower (p = 0.007), and highest concavity peak distance (HCPD) was significantly higher (p = 0.034) in the DAI-CXL group compared to the A-CXL group. A significant increase in applanation 1 velocity (A1V), HCPD, and deformation amplitude (DA) (p = 0.03, 0.007, 0.02, respectively) and a decrease in Ambrósio relational thickness to the horizontal profile (ARTh) (p < 0.001) were noted in the A-CXL group at 12 months. The DAI-CXL group showed a significant decrease in HCT, integrated radius (IR), and ARTh (p = 0.006, 0.011, 0.009, respectively) between baseline and postoperative assessments. Corvis Biomechanical Factor (CBiF) and E-stage remained stable in both groups.ConclusionDAI-CXL and A-CXL demonstrate comparable efficacy in achieving visual, topographic, and biomechanical stabilization in progressive keratoconus over a 12-month period.
目的比较加速交联(A-CXL)与稀释酒精离子连接辅助角膜交联(DAI-CXL)后角膜的生物力学特性。方法对41例进展性圆锥角膜行DAI-CXL或A-CXL的患者49只眼进行分析。术前和术后12个月分别分析视力、地形和生物力学数据。结果A-CXL组平角膜测量(K1)和最薄角膜厚度(TCT)较基线和术后显著降低(K1, p = 0.001;TCT: p = 0.007)。与a - cxl组相比,DAI-CXL组的陡角度数(K2)和最大角度数(Kmax)均显著降低(K2: p = 0.03, p p p = 0.007),最高凹峰距离(HCPD)显著升高(p = 0.034)。在基线和术后评估中,压平速度(A1V)、HCPD和变形幅度(DA)显著增加(p分别= 0.03、0.007、0.02),Ambrósio水平剖面相关厚度(ARTh)显著减少(p分别= 0.006、0.011、0.009)。两组患者的克维斯生物力学因子(cif)和e期均保持稳定。结论dai - cxl和a - cxl在12个月的进展性圆锥角膜的视觉、地形和生物力学稳定方面具有相当的疗效。
{"title":"Topographic and biomechanical comparison of diluted alcohol and iontophoresis-assisted versus accelerated corneal crosslinking in keratoconus.","authors":"Caglar Bektas, Betul Seher Uysal, Hasan Diker, Mehmet Cuneyt Ozmen, Kamil Bilgihan","doi":"10.1177/11206721251364409","DOIUrl":"10.1177/11206721251364409","url":null,"abstract":"<p><p>PurposeTo compare the corneal biomechanical characteristics following accelerated cross-linking (A-CXL) and diluted alcohol and iontophoresis-assisted corneal cross-linking (DAI-CXL).MethodsForty-nine eyes from 41 patients who underwent DAI-CXL or A-CXL for progressive keratoconus were included. Visual acuity, topographic, and biomechanical data were analyzed preoperatively and 12 months postoperatively.ResultsA significant decrease in flat keratometry (K1) and thinnest corneal thickness (TCT) was observed in the A-CXL group between baseline and postoperatively (K1, <i>p</i> = 0.001; TCT: <i>p</i> = 0.007). Both groups showed a significant decrease in steep keratometry (K2) and maximum keratometry (Kmax) compared to baseline (K2: <i>p</i> = 0.03, <i>p</i> < 0.001, respectively; Kmax: <i>p</i> < 0.001 for both groups). Postoperatively, highest concavity time (HCT) was significantly lower (<i>p</i> = 0.007), and highest concavity peak distance (HCPD) was significantly higher (<i>p</i> = 0.034) in the DAI-CXL group compared to the A-CXL group. A significant increase in applanation 1 velocity (A1V), HCPD, and deformation amplitude (DA) (<i>p</i> = 0.03, 0.007, 0.02, respectively) and a decrease in Ambrósio relational thickness to the horizontal profile (ARTh) (<i>p</i> < 0.001) were noted in the A-CXL group at 12 months. The DAI-CXL group showed a significant decrease in HCT, integrated radius (IR), and ARTh (<i>p</i> = 0.006, 0.011, 0.009, respectively) between baseline and postoperative assessments. Corvis Biomechanical Factor (CBiF) and E-stage remained stable in both groups.ConclusionDAI-CXL and A-CXL demonstrate comparable efficacy in achieving visual, topographic, and biomechanical stabilization in progressive keratoconus over a 12-month period.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"24-33"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144816077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-01DOI: 10.1177/11206721251372379
Lily Silva Ardiani, Aknes Sintiya Dewi, Johan Arif Hutauruk, Sharita Rosalyne Siregar
There are some disputes regarding the necessity of maintaining a supine position after endothelial keratoplasty (EK) to ensure graft attachment. We aimed to evaluate the efficacy of a supine position after EK in reducing the risk of postoperative graft detachment. This systematic review with meta-analysis was registered in PROSPERO under protocol CRD42024541226. PubMed, Scopus, Embase, and Cochrane Central Register of Controlled Trials databases were systematically searched for studies comparing non-supine versus supine positions after EK. We pooled risk ratios (RR) and 95% confidence intervals (CI) for dichotomous outcomes and mean differences (MD) with 95% CI for continuous outcomes using a random-effects model. We included two randomized controlled trials and two observational studies comprising 456 eyes, of which 173 (37.9%) were assigned to non-supine positions. There were no significant differences in the incidence of graft detachment (RR 1.09; 95% CI 0.52-2.26; p = 0.82), rebubbling rate (RR 1.05; 95% CI 0.46-2.41; p = 0.90) and need for repeat keratoplasty (RR 2.37; 95% CI 0.13-41.99; p = 0.56) between non-supine and supine groups. There was also no difference in visual acuity (MD -0.02 LogMAR; 95% CI -0.11-0.08; p = 0.75) and intraocular pressure (MD -1.44 mmHg; 95% CI -8.49-5.61; p = 0.69) between groups. Subgroup analysis of DMEK (RR 0.73; 95% CI 0.38-1.42; p = 0.35) and DSAEK (RR 1.96; 95% CI 0.95-4.04; p = 0.07) also showed no difference in graft detachment between groups. Maintaining a supine position after EK surgery did not significantly affect graft detachment, rebubbling rate, need for repeat keratoplasty, visual acuity, or intraocular pressure.
关于角膜内皮移植术(EK)后维持仰卧位以确保移植物附着的必要性,存在一些争议。我们的目的是评估EK术后仰卧位在降低术后移植物脱离风险方面的疗效。该系统评价纳入meta分析,在PROSPERO注册,注册方案为CRD42024541226。系统地检索PubMed、Scopus、Embase和Cochrane中央对照试验注册数据库,比较EK术后非仰卧位和仰卧位的研究。我们使用随机效应模型汇总了二分类结局的风险比(RR)和95%置信区间(CI),以及连续结局的平均差异(MD)和95% CI。我们纳入了两项随机对照试验和两项观察性研究,包括456只眼睛,其中173只(37.9%)被分配到非仰卧位。非仰卧位组和仰卧位组在角膜移植脱离发生率(RR 1.09; 95% CI 0.52-2.26; p = 0.82)、再泡率(RR 1.05; 95% CI 0.46-2.41; p = 0.90)和需要重复角膜移植(RR 2.37; 95% CI 0.13-41.99; p = 0.56)方面无显著差异。两组之间的视力(MD -0.02 LogMAR; 95% CI -0.11-0.08; p = 0.75)和眼压(MD -1.44 mmHg; 95% CI -8.49-5.61; p = 0.69)也无差异。DMEK (RR 0.73; 95% CI 0.38-1.42; p = 0.35)和DSAEK (RR 1.96; 95% CI 0.95-4.04; p = 0.07)的亚组分析也显示两组间移骨脱离无差异。EK手术后保持仰卧位对移植物脱离、再泡率、重复角膜移植的需要、视力或眼压没有显著影响。
{"title":"Non-supine versus supine position after endothelial keratoplasty: A systematic review and meta-analysis.","authors":"Lily Silva Ardiani, Aknes Sintiya Dewi, Johan Arif Hutauruk, Sharita Rosalyne Siregar","doi":"10.1177/11206721251372379","DOIUrl":"10.1177/11206721251372379","url":null,"abstract":"<p><p>There are some disputes regarding the necessity of maintaining a supine position after endothelial keratoplasty (EK) to ensure graft attachment. We aimed to evaluate the efficacy of a supine position after EK in reducing the risk of postoperative graft detachment. This systematic review with meta-analysis was registered in PROSPERO under protocol CRD42024541226. PubMed, Scopus, Embase, and Cochrane Central Register of Controlled Trials databases were systematically searched for studies comparing non-supine versus supine positions after EK. We pooled risk ratios (RR) and 95% confidence intervals (CI) for dichotomous outcomes and mean differences (MD) with 95% CI for continuous outcomes using a random-effects model. We included two randomized controlled trials and two observational studies comprising 456 eyes, of which 173 (37.9%) were assigned to non-supine positions. There were no significant differences in the incidence of graft detachment (RR 1.09; 95% CI 0.52-2.26; <i>p</i> = 0.82), rebubbling rate (RR 1.05; 95% CI 0.46-2.41; <i>p</i> = 0.90) and need for repeat keratoplasty (RR 2.37; 95% CI 0.13-41.99; <i>p</i> = 0.56) between non-supine and supine groups. There was also no difference in visual acuity (MD -0.02 LogMAR; 95% CI -0.11-0.08; <i>p</i> = 0.75) and intraocular pressure (MD -1.44 mmHg; 95% CI -8.49-5.61; <i>p</i> = 0.69) between groups. Subgroup analysis of DMEK (RR 0.73; 95% CI 0.38-1.42; <i>p</i> = 0.35) and DSAEK (RR 1.96; 95% CI 0.95-4.04; <i>p</i> = 0.07) also showed no difference in graft detachment between groups. Maintaining a supine position after EK surgery did not significantly affect graft detachment, rebubbling rate, need for repeat keratoplasty, visual acuity, or intraocular pressure.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"164-173"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PurposeTo compare and evaluate the diagnostic performance of OCT-angiography (OCT-A) parameters in diabetic retinopathy (DR) detection compared to fluorescein angiography (FA).MethodsThis is a cross-sectional, prospective study including 118 diabetic patients (214 eyes). All patients had a complete clinical examination with FA as well as macular OCT-A imaging (3 × 3 mm, 6 × 6 mm). We compared the detection of fundamental DR lesions using both imaging modalities and assessed the diagnostic value of different OCT-A parameters.ResultsMicroaneurysms were more frequently detected by FA than with OCT-A. Intraretinal microvascular anomalies were equally visualized by OCT-A (0.27 ± 0.777) and FA (0.27 ± 0.71). Average of foveal avascular zone (FAZ) surface was less significant at superficial capillary plexus (SCP) (0.353 ± 0.107 mm²) compared to deep capillary plexus (DCP) (0.537 ± 0,135 mm²), (p < 0.001). FAZ remodeling was observed even in DR free eyes and was better identified in DCP (61.1%) than SCP (47.2%). Loss of FAZ circularity was estimated at 0.792 ± 0.081 and 0.741 ± 0.107 respectively in SCP and DCP, (p < 0.001). Average surface area of capillary non-perfusion zones (CNPZ) was 0.487 ± 0.514 mm² in SCP and 0.145 ± 0.223 mm² in DCP, (p < 0.001). The Most reliable OCT-A quantitative parameters for DR screening were: CNPZ surface in DCP (p = 0.0046), total vascular density (VDt) in the DCP (p = 0.003) and CNPZ surface in the SCP (p = 0.0027).ConclusionOCT-A enables diabetic microvascular abnormalities detection even at a preclinical stage. Certain OCT-A parameters may provide a valuable quantitative approach for diagnosis and grading of DR severity.
{"title":"Comparative analysis of OCT-angiography and fluorescein angiography in imaging diabetic retinopathy: Unveiling new diagnostic insights.","authors":"Khallouli Asma, Oueslati Yassin, Lagneb Cyrine, Choura Racem, Bouchoucha Saker, Maalej Afef","doi":"10.1177/11206721251367571","DOIUrl":"10.1177/11206721251367571","url":null,"abstract":"<p><p>PurposeTo compare and evaluate the diagnostic performance of OCT-angiography (OCT-A) parameters in diabetic retinopathy (DR) detection compared to fluorescein angiography (FA).MethodsThis is a cross-sectional, prospective study including 118 diabetic patients (214 eyes). All patients had a complete clinical examination with FA as well as macular OCT-A imaging (3 × 3 mm, 6 × 6 mm). We compared the detection of fundamental DR lesions using both imaging modalities and assessed the diagnostic value of different OCT-A parameters.ResultsMicroaneurysms were more frequently detected by FA than with OCT-A. Intraretinal microvascular anomalies were equally visualized by OCT-A (0.27 ± 0.777) and FA (0.27 ± 0.71). Average of foveal avascular zone (FAZ) surface was less significant at superficial capillary plexus (SCP) (0.353 ± 0.107 mm²) compared to deep capillary plexus (DCP) (0.537 ± 0,135 mm²), (p < 0.001). FAZ remodeling was observed even in DR free eyes and was better identified in DCP (61.1%) than SCP (47.2%). Loss of FAZ circularity was estimated at 0.792 ± 0.081 and 0.741 ± 0.107 respectively in SCP and DCP, (p < 0.001). Average surface area of capillary non-perfusion zones (CNPZ) was 0.487 ± 0.514 mm² in SCP and 0.145 ± 0.223 mm² in DCP, (p < 0.001). The Most reliable OCT-A quantitative parameters for DR screening were: CNPZ surface in DCP (p = 0.0046), total vascular density (VDt) in the DCP (p = 0.003) and CNPZ surface in the SCP (p = 0.0027).ConclusionOCT-A enables diabetic microvascular abnormalities detection even at a preclinical stage. Certain OCT-A parameters may provide a valuable quantitative approach for diagnosis and grading of DR severity.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"58-66"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144820964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-08-19DOI: 10.1177/11206721251364120
Palak R Patel, Rohan A Jalalizadeh, Bradley T Smith
AimTo determine the value of central choroidal thickness (CCT) as a clinical marker in differentiating peripheral retinoschisis (PRS) and macula-on rhegmatogenous retinal detachments (mac-on RRD).MethodsIn this cross-sectional study, eyes with PRS from January 2012 to May 2021 and mac-on RRD from January 2017 to January 2019 were identified. Macular pathology was exclusionary. CCT was classified as thin, normal, or thick for all eyes. Primary outcomes assessed the proportion of eyes within each diagnostic category with thin, normal, and thick CCT.ResultsOne-hundred and sixty eyes with PRS and 59 eyes with mac-on RRD were identified. Thick (65.6%) or normal (25.0%) CCT was noted in 90.6% of eyes with PRS, while only 9.4% had thin CCT. Thin (52.5%) or normal (30.5%) CCT was noted in 83.0% of eyes with mac-on RRD, whereas only 17.0% had thick CCT's. Thick CCT was significantly observed in PRS (p < 0.0001), while thin CCT was significantly observed in mac-on RRD (p < 0.0001).ConclusionIn the absence of known refractive error or axial length, CCT may serve as a useful and readily available diagnostic tool when attempting to distinguish between two often clinically similar retinal pathologies - PRS and mac-on RRD.
{"title":"Choroidal thickness as a clinical marker in differentiating peripheral retinoschisis and retinal detachments.","authors":"Palak R Patel, Rohan A Jalalizadeh, Bradley T Smith","doi":"10.1177/11206721251364120","DOIUrl":"10.1177/11206721251364120","url":null,"abstract":"<p><p>AimTo determine the value of central choroidal thickness (CCT) as a clinical marker in differentiating peripheral retinoschisis (PRS) and macula-on rhegmatogenous retinal detachments (mac-on RRD).MethodsIn this cross-sectional study, eyes with PRS from January 2012 to May 2021 and mac-on RRD from January 2017 to January 2019 were identified. Macular pathology was exclusionary. CCT was classified as thin, normal, or thick for all eyes. Primary outcomes assessed the proportion of eyes within each diagnostic category with thin, normal, and thick CCT.ResultsOne-hundred and sixty eyes with PRS and 59 eyes with mac-on RRD were identified. Thick (65.6%) or normal (25.0%) CCT was noted in 90.6% of eyes with PRS, while only 9.4% had thin CCT. Thin (52.5%) or normal (30.5%) CCT was noted in 83.0% of eyes with mac-on RRD, whereas only 17.0% had thick CCT's. Thick CCT was significantly observed in PRS (<i>p</i> < 0.0001), while thin CCT was significantly observed in mac-on RRD (<i>p</i> < 0.0001).ConclusionIn the absence of known refractive error or axial length, CCT may serve as a useful and readily available diagnostic tool when attempting to distinguish between two often clinically similar retinal pathologies - PRS and mac-on RRD.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"119-126"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144882498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-08-25DOI: 10.1177/11206721251372393
Talha Soorma, Luciane Dreher Irion, Andrew James Walkden, Amira Stylianides
IntroductionConjunctival involvement in sarcoidosis typically presents as non-scarring granulomatous inflammation; however, cicatricial conjunctivitis represents a rare and poorly characterised manifestation. There are currently no published reports of sarcoid-related conjunctival granulomas with cicatrising features responding to anti-TNF therapy. We present the first case of biopsy-confirmed conjunctival sarcoidosis with progressive scarring successfully treated with adalimumab after failure of conventional immunosuppression.Case DescriptionA 47-year-old male with biopsy-proven systemic sarcoidosis presented with recurrent anterior uveitis and progressive conjunctival granulomas, unresponsive to corticosteroids and mycophenolate. He developed forniceal foreshortening, symblepharon formation, and a dense cataract. Conjunctival biopsy confirmed non-necrotizing granulomatous inflammation. Adalimumab was initiated following disease progression on conventional therapy. Within six months, ocular surface inflammation resolved, enabling successful cataract surgery and visual rehabilitation.ConclusionTo our knowledge, this is the first documented case of sarcoid-related cicatricial conjunctivitis with histological confirmation responding favourably to anti-TNF therapy. This report suggests adalimumab may be a valuable option in cases of treatment-resistant ocular surface sarcoidosis and may guide future therapeutic decision-making.
{"title":"Sarcoid conjunctival granuloma responding to biological therapy.","authors":"Talha Soorma, Luciane Dreher Irion, Andrew James Walkden, Amira Stylianides","doi":"10.1177/11206721251372393","DOIUrl":"10.1177/11206721251372393","url":null,"abstract":"<p><p>IntroductionConjunctival involvement in sarcoidosis typically presents as non-scarring granulomatous inflammation; however, cicatricial conjunctivitis represents a rare and poorly characterised manifestation. There are currently no published reports of sarcoid-related conjunctival granulomas with cicatrising features responding to anti-TNF therapy. We present the first case of biopsy-confirmed conjunctival sarcoidosis with progressive scarring successfully treated with adalimumab after failure of conventional immunosuppression.Case DescriptionA 47-year-old male with biopsy-proven systemic sarcoidosis presented with recurrent anterior uveitis and progressive conjunctival granulomas, unresponsive to corticosteroids and mycophenolate. He developed forniceal foreshortening, symblepharon formation, and a dense cataract. Conjunctival biopsy confirmed non-necrotizing granulomatous inflammation. Adalimumab was initiated following disease progression on conventional therapy. Within six months, ocular surface inflammation resolved, enabling successful cataract surgery and visual rehabilitation.ConclusionTo our knowledge, this is the first documented case of sarcoid-related cicatricial conjunctivitis with histological confirmation responding favourably to anti-TNF therapy. This report suggests adalimumab may be a valuable option in cases of treatment-resistant ocular surface sarcoidosis and may guide future therapeutic decision-making.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"NP5-NP9"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PurposeSinonasal mucosal melanoma (SNMM) accounts for approximately 4-8% of sinonasal malignancies. SNMM frequently originates in the nasal cavity, causing nonspecific nasal symptoms that inevitably delay diagnosis. Left untreated, the tumor may extend into the orbit.Case DescriptionHerein, the authors describe two patients presenting with compressive optic neuropathy and were found to have advanced SNMM involving the orbit. Both patients presented with vision loss, decreased color vision, proptosis, conjunctival chemosis, and restricted extraocular movements. One patient was found to have a relative afferent pupillary defect. Neither patient was a surgical candidate, and both received palliative radiotherapy and immunotherapy.ConclusionsThese cases and literature review demonstrate the potential for the disease to initially manifest with orbital extension and ocular symptoms. Ophthalmologists can play a crucial role in the early detection of SNMM, which may improve outcomes, given the challenges of SNMM treatment.
{"title":"Sinonasal mucosal melanoma presenting with ocular symptoms: Two case reports and a literature review.","authors":"Kelsey Donovan, Narmien Murdock, Marielle Mahan, Viraj Mehta","doi":"10.1177/11206721251370912","DOIUrl":"10.1177/11206721251370912","url":null,"abstract":"<p><p>PurposeSinonasal mucosal melanoma (SNMM) accounts for approximately 4-8% of sinonasal malignancies. SNMM frequently originates in the nasal cavity, causing nonspecific nasal symptoms that inevitably delay diagnosis. Left untreated, the tumor may extend into the orbit.Case DescriptionHerein, the authors describe two patients presenting with compressive optic neuropathy and were found to have advanced SNMM involving the orbit. Both patients presented with vision loss, decreased color vision, proptosis, conjunctival chemosis, and restricted extraocular movements. One patient was found to have a relative afferent pupillary defect. Neither patient was a surgical candidate, and both received palliative radiotherapy and immunotherapy.ConclusionsThese cases and literature review demonstrate the potential for the disease to initially manifest with orbital extension and ocular symptoms. Ophthalmologists can play a crucial role in the early detection of SNMM, which may improve outcomes, given the challenges of SNMM treatment.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"NP10-NP15"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectiveTo analyze and compare the accuracy of different intraocular lens power calculation formulas in patients with cataract after radial keratotomy.MethodsWeb of Science, Cochrane Library, EMBASE and PubMed were searched for clinical studies published from the establishment of the database to 10th May 2024. Measurements were taken as percentage of eyes of prediction errors within ±0.5 D and ±1.0 D. A network meta-analysis was utilized to compare the different formulas as a way to identify the most advantageous ones.ResultsResults from 11 studies of 674 eyes after radial keratotomy that used 24 formulas were included. A network meta-analysis indicated that for error within the range of ± 0.5 D, Barrett true-K History and Barrett true-K Partial History were better than Double-K Holladay 1. Intraoperative Aberrometry, Double-K SRK/T, Haigis and Barrett true-K No History performed as well or better than Double-K Holladay 1. Shammas No History and Holladay 1 had poor performance. For error within the range of ±1.0 D, Shammas No History and Barrett Universal II had poor performance. No statistically significant difference was observed between the other formulas.ConclusionsFor cataract patients after radial keratotomy, Barrett true-K History and Barrett true-K Partial History were recommended if the prior medical history were available. Otherwise, no single formula is more advantageous without reference to prior medical history.
目的分析比较桡骨角膜切开术后白内障不同人工晶状体度数计算公式的准确性。方法检索web of Science、Cochrane Library、EMBASE和PubMed数据库自建库至2024年5月10日发表的临床研究。测量结果为预测误差在±0.5 D和±1.0 D范围内的眼的百分比。采用网络荟萃分析比较不同的公式,以确定最有利的公式。结果纳入11项研究,674只眼桡骨角膜切开术后使用24种配方。网络荟萃分析表明,在±0.5 D范围内,Barrett真k史和Barrett真k部分史优于Double-K Holladay 1。术中像差测量、Double-K SRK/T、Haigis和Barrett true-K No History均优于Double-K Holladay 1。Shammas No History和Holladay 1表现不佳。误差在±1.0 D范围内,Shammas No History和Barrett Universal II表现不佳。其他公式之间无统计学差异。结论对于桡骨角膜切开术后的白内障患者,如有既往病史,建议进行Barrett真k史和Barrett真k部分史检查。否则,没有一个单一的配方是更有利的,没有参考先前的病史。
{"title":"Intraocular lens power calculation formulas in 674 cataract eyes after radial keratotomy: Bayesian network meta-analysis.","authors":"Zhao-Xing Guo, Meng Li, Jing-Shang Zhang, Ying-Yan Mao, Zhi-Yong Tian, Xin Zheng, Xiu-Hua Wan","doi":"10.1177/11206721251374370","DOIUrl":"10.1177/11206721251374370","url":null,"abstract":"<p><p>ObjectiveTo analyze and compare the accuracy of different intraocular lens power calculation formulas in patients with cataract after radial keratotomy.MethodsWeb of Science, Cochrane Library, EMBASE and PubMed were searched for clinical studies published from the establishment of the database to 10th May 2024. Measurements were taken as percentage of eyes of prediction errors within ±0.5 D and ±1.0 D. A network meta-analysis was utilized to compare the different formulas as a way to identify the most advantageous ones.ResultsResults from 11 studies of 674 eyes after radial keratotomy that used 24 formulas were included. A network meta-analysis indicated that <b>for error within the range of ± 0.5 D,</b> Barrett true-K History and Barrett true-K Partial History were better than Double-K Holladay 1. Intraoperative Aberrometry, Double-K SRK/T, Haigis and Barrett true-K No History performed as well or better than Double-K Holladay 1. Shammas No History and Holladay 1 had poor performance. <b>For error within the range of ±1.0 D,</b> Shammas No History and Barrett Universal II had poor performance. No statistically significant difference was observed between the other formulas.ConclusionsFor cataract patients after radial keratotomy, Barrett true-K History and Barrett true-K Partial History were recommended if the prior medical history were available. Otherwise, no single formula is more advantageous without reference to prior medical history.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"13-23"},"PeriodicalIF":1.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145074690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26DOI: 10.1177/11206721251397694
Tu-An Ma, Luke K Chehade, Shane Durkin, Weng O Chan
{"title":"Large asymptomatic intraocular silicone oil droplet following intravitreal injection.","authors":"Tu-An Ma, Luke K Chehade, Shane Durkin, Weng O Chan","doi":"10.1177/11206721251397694","DOIUrl":"https://doi.org/10.1177/11206721251397694","url":null,"abstract":"","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251397694"},"PeriodicalIF":1.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26DOI: 10.1177/11206721251408667
Doğukan Cömerter, Feyza Rümeysa Öz
PurposeTo present the first case of multifocal vitelliform paravascular retinopathy (MVPR) identified in Turkey and to describe its multimodal imaging features and clinical course.MethodsA 59-year-old woman underwent a routine ophthalmic examination during evaluation for a chalazion. Comprehensive multimodal imaging, including fundus photography, fundus autofluorescence (FAF), optical coherence tomography (OCT), and fluorescein angiography (FA), was performed.ResultsBest-corrected visual acuity was 20/20 in both eyes. Fundus examination revealed multiple, small, round, yellow-white lesions distributed along the vascular arcades and surrounding the macula bilaterally. FAF showed predominantly hypoautofluorescent lesions with areas of mixed hypo- and hyperautofluorescence. OCT sections through the lesions demonstrated disruption of the ellipsoid zone and dome-shaped hyporeflective cavities in the outer retina, while FA revealed hyperfluorescent lesions ( Figure 1). The patient had a history of diabetes and hypertension but no other systemic or ocular disease. Laboratory and systemic imaging findings were unremarkable. Full-field ERG and EOG were within normal limits.ConclusionThis case represents the first reported instance of MVPR in Turkey. The imaging features and benign, asymptomatic clinical course were consistent with those of previously reported MVPR cases. Further studies are required to clarify the underlying pathophysiology and long-term prognosis of this newly described condition.
{"title":"Multimodal imaging of multifocal vitelliform paravascular retinopathy.","authors":"Doğukan Cömerter, Feyza Rümeysa Öz","doi":"10.1177/11206721251408667","DOIUrl":"10.1177/11206721251408667","url":null,"abstract":"<p><p>PurposeTo present the first case of multifocal vitelliform paravascular retinopathy (MVPR) identified in Turkey and to describe its multimodal imaging features and clinical course.MethodsA 59-year-old woman underwent a routine ophthalmic examination during evaluation for a chalazion. Comprehensive multimodal imaging, including fundus photography, fundus autofluorescence (FAF), optical coherence tomography (OCT), and fluorescein angiography (FA), was performed.ResultsBest-corrected visual acuity was 20/20 in both eyes. Fundus examination revealed multiple, small, round, yellow-white lesions distributed along the vascular arcades and surrounding the macula bilaterally. FAF showed predominantly hypoautofluorescent lesions with areas of mixed hypo- and hyperautofluorescence. OCT sections through the lesions demonstrated disruption of the ellipsoid zone and dome-shaped hyporeflective cavities in the outer retina, while FA revealed hyperfluorescent lesions ( Figure 1). The patient had a history of diabetes and hypertension but no other systemic or ocular disease. Laboratory and systemic imaging findings were unremarkable. Full-field ERG and EOG were within normal limits.ConclusionThis case represents the first reported instance of MVPR in Turkey. The imaging features and benign, asymptomatic clinical course were consistent with those of previously reported MVPR cases. Further studies are required to clarify the underlying pathophysiology and long-term prognosis of this newly described condition.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251408667"},"PeriodicalIF":1.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}